Flt3 does not play a critical role in murine myeloid leukemias induced by MLL fusion genes.
Leukemias harboring MLL translocations are frequent in children and adults, and respond poorly to therapies. The receptor tyrosine kinase FLT3 is highly expressed in these leukemias. In vitro studies have shown that pediatric MLL-rearranged ALL cells are sensitive to FLT3 inhibitors and clinical tri...
Main Authors: | Stéphanie Albouhair, Ester Morgado, Catherine Lavau |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2013-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3745452?pdf=render |
Similar Items
-
Zebrafish Model of MLL-Rearranged Acute Myeloid Leukemia
by: Belt, Alex J
Published: (2018) -
SYK Is a Critical Regulator of FLT3 in Acute Myeloid Leukemia
by: Puissant, Alexandre, et al.
Published: (2017) -
Comparison of FLT3 inhibitors with the standard treatment for FLT3-ITD mutated acute myeloid leukemia
by: Argetsinger, Stephanie
Published: (2019) -
FLT3 inhibitors in acute myeloid leukemia
by: Mei Wu, et al.
Published: (2018-12-01) -
Identification of genes transcriptionally responsive to the loss of MLL fusions in MLL-rearranged acute lymphoblastic leukemia.
by: Marieke H van der Linden, et al.
Published: (2015-01-01)